• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Promedior Inc - Articles and news items

BMS gets exclusive rights to acquire Promedior

Industry news / 2 September 2015 / Victoria White

As well as granting exclusive rights to acquire Promedior, the agreement grants Bristol-Myers Squibb worldwide rights to Promedior’s lead asset PRM-151.


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +